Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
38
SKHHY Quote, Financials, Valuation and Earnings
Last price:
$15.14
Seasonality move
:
0.29%
Day range:
$14.40 - $15.24
52-week range:
$13.00 - $19.25
Dividend yield:
4.63%
P/E ratio:
21.85x
P/S ratio:
1.18x
P/B ratio:
1.71x
Volume:
138.9K
Avg. volume:
180K
1-year change:
-11.77%
Market cap:
$7.5B
Revenue:
$6.1B
EPS (TTM):
$0.69
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SKHHY
Sonic Healthcare Ltd.
|
-- | -- | -- | -- | -- |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -- | -- | -- | $12.00 |
|
IMMP
Immutep Ltd.
|
-- | -- | -- | -- | $9.50 |
|
KZIA
Kazia Therapeutics Ltd.
|
-- | -- | -- | -- | $19.01 |
|
MESO
Mesoblast Ltd.
|
$20.3M | -- | -100% | -- | $35.00 |
|
PPCB
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SKHHY
Sonic Healthcare Ltd.
|
$15.08 | -- | $7.5B | 21.85x | $0.42 | 4.63% | 1.18x |
|
ATHE
Alterity Therapeutics Ltd.
|
$3.09 | $12.00 | $56M | -- | $0.00 | 0% | 3.58x |
|
IMMP
Immutep Ltd.
|
$2.63 | $9.50 | $382.8M | -- | $0.00 | 0% | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
$10.87 | $19.01 | $18.2M | -- | $0.00 | 0% | 491.15x |
|
MESO
Mesoblast Ltd.
|
$19.48 | $35.00 | $2.5B | -- | $0.00 | 0% | 136.71x |
|
PPCB
|
$11.98 | -- | $158.1K | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SKHHY
Sonic Healthcare Ltd.
|
36.93% | 0.445 | -- | 0.84x |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -1.575 | -- | -- |
|
IMMP
Immutep Ltd.
|
-- | 0.640 | -- | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
-6.76% | 5.445 | 5.57% | 0.07x |
|
MESO
Mesoblast Ltd.
|
-- | 0.345 | -- | -- |
|
PPCB
|
-- | 4.794 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SKHHY
Sonic Healthcare Ltd.
|
-- | -- | 4.54% | 6.72% | -- | -- |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -- | -- | -- | -- | -- |
|
IMMP
Immutep Ltd.
|
-- | -- | -- | -- | -- | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
-- | -- | -784.09% | -1083.16% | -- | -- |
|
MESO
Mesoblast Ltd.
|
-- | -- | -- | -- | -- | -- |
|
PPCB
|
-- | -$290.8K | -- | -- | -- | -$235.5K |
Sonic Healthcare Ltd. vs. Competitors
-
Which has Higher Returns SKHHY or ATHE?
Alterity Therapeutics Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Alterity Therapeutics Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHHYSonic Healthcare Ltd.-- -- $8.2B ATHEAlterity Therapeutics Ltd.-- -- -- -
What do Analysts Say About SKHHY or ATHE?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Alterity Therapeutics Ltd. has an analysts' consensus of $12.00 which suggests that it could grow by 288.35%. Given that Alterity Therapeutics Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Alterity Therapeutics Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHHYSonic Healthcare Ltd.0 0 0 ATHEAlterity Therapeutics Ltd.0 0 0 -
Is SKHHY or ATHE More Risky?
Sonic Healthcare Ltd. has a beta of 1.066, which suggesting that the stock is 6.569% more volatile than S&P 500. In comparison Alterity Therapeutics Ltd. has a beta of 0.023, suggesting its less volatile than the S&P 500 by 97.656%.
-
Which is a Better Dividend Stock SKHHY or ATHE?
Sonic Healthcare Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 4.63%. Alterity Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 89.9% of its earnings as a dividend. Alterity Therapeutics Ltd. pays out -- of its earnings as a dividend. Sonic Healthcare Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SKHHY or ATHE?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Alterity Therapeutics Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Alterity Therapeutics Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 21.85x while Alterity Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.18x versus 3.58x for Alterity Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHHYSonic Healthcare Ltd.1.18x 21.85x -- -- ATHEAlterity Therapeutics Ltd.3.58x -- -- --
-
Which has Higher Returns SKHHY or IMMP?
Immutep Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Immutep Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHHYSonic Healthcare Ltd.-- -- $8.2B IMMPImmutep Ltd.-- -- -- -
What do Analysts Say About SKHHY or IMMP?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Immutep Ltd. has an analysts' consensus of $9.50 which suggests that it could grow by 261.22%. Given that Immutep Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Immutep Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHHYSonic Healthcare Ltd.0 0 0 IMMPImmutep Ltd.1 0 0 -
Is SKHHY or IMMP More Risky?
Sonic Healthcare Ltd. has a beta of 1.066, which suggesting that the stock is 6.569% more volatile than S&P 500. In comparison Immutep Ltd. has a beta of 1.925, suggesting its more volatile than the S&P 500 by 92.469%.
-
Which is a Better Dividend Stock SKHHY or IMMP?
Sonic Healthcare Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 4.63%. Immutep Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 89.9% of its earnings as a dividend. Immutep Ltd. pays out -- of its earnings as a dividend. Sonic Healthcare Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SKHHY or IMMP?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Immutep Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Immutep Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 21.85x while Immutep Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.18x versus -- for Immutep Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHHYSonic Healthcare Ltd.1.18x 21.85x -- -- IMMPImmutep Ltd.-- -- -- --
-
Which has Higher Returns SKHHY or KZIA?
Kazia Therapeutics Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Kazia Therapeutics Ltd.'s return on equity of -1083.16%.
Company Gross Margin Earnings Per Share Invested Capital SKHHYSonic Healthcare Ltd.-- -- $8.2B KZIAKazia Therapeutics Ltd.-- -- -$6.3M -
What do Analysts Say About SKHHY or KZIA?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Kazia Therapeutics Ltd. has an analysts' consensus of $19.01 which suggests that it could grow by 75.2%. Given that Kazia Therapeutics Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Kazia Therapeutics Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHHYSonic Healthcare Ltd.0 0 0 KZIAKazia Therapeutics Ltd.1 0 0 -
Is SKHHY or KZIA More Risky?
Sonic Healthcare Ltd. has a beta of 1.066, which suggesting that the stock is 6.569% more volatile than S&P 500. In comparison Kazia Therapeutics Ltd. has a beta of 1.672, suggesting its more volatile than the S&P 500 by 67.185%.
-
Which is a Better Dividend Stock SKHHY or KZIA?
Sonic Healthcare Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 4.63%. Kazia Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 89.9% of its earnings as a dividend. Kazia Therapeutics Ltd. pays out -- of its earnings as a dividend. Sonic Healthcare Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SKHHY or KZIA?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Kazia Therapeutics Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Kazia Therapeutics Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 21.85x while Kazia Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.18x versus 491.15x for Kazia Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHHYSonic Healthcare Ltd.1.18x 21.85x -- -- KZIAKazia Therapeutics Ltd.491.15x -- -- --
-
Which has Higher Returns SKHHY or MESO?
Mesoblast Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Mesoblast Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHHYSonic Healthcare Ltd.-- -- $8.2B MESOMesoblast Ltd.-- -- -- -
What do Analysts Say About SKHHY or MESO?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Mesoblast Ltd. has an analysts' consensus of $35.00 which suggests that it could grow by 79.67%. Given that Mesoblast Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Mesoblast Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHHYSonic Healthcare Ltd.0 0 0 MESOMesoblast Ltd.1 0 0 -
Is SKHHY or MESO More Risky?
Sonic Healthcare Ltd. has a beta of 1.066, which suggesting that the stock is 6.569% more volatile than S&P 500. In comparison Mesoblast Ltd. has a beta of 2.025, suggesting its more volatile than the S&P 500 by 102.508%.
-
Which is a Better Dividend Stock SKHHY or MESO?
Sonic Healthcare Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 4.63%. Mesoblast Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 89.9% of its earnings as a dividend. Mesoblast Ltd. pays out -- of its earnings as a dividend. Sonic Healthcare Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SKHHY or MESO?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Mesoblast Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Mesoblast Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 21.85x while Mesoblast Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.18x versus 136.71x for Mesoblast Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHHYSonic Healthcare Ltd.1.18x 21.85x -- -- MESOMesoblast Ltd.136.71x -- -- --
-
Which has Higher Returns SKHHY or PPCB?
has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat 's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHHYSonic Healthcare Ltd.-- -- $8.2B PPCB-- -$0.00 -- -
What do Analysts Say About SKHHY or PPCB?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand has an analysts' consensus of -- which suggests that it could fall by --. Given that Sonic Healthcare Ltd. has higher upside potential than , analysts believe Sonic Healthcare Ltd. is more attractive than .
Company Buy Ratings Hold Ratings Sell Ratings SKHHYSonic Healthcare Ltd.0 0 0 PPCB0 0 0 -
Is SKHHY or PPCB More Risky?
Sonic Healthcare Ltd. has a beta of 1.066, which suggesting that the stock is 6.569% more volatile than S&P 500. In comparison has a beta of 1.881, suggesting its more volatile than the S&P 500 by 88.104%.
-
Which is a Better Dividend Stock SKHHY or PPCB?
Sonic Healthcare Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 4.63%. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 89.9% of its earnings as a dividend. pays out -- of its earnings as a dividend. Sonic Healthcare Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SKHHY or PPCB?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than 's net income of -$354.3K. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 21.85x while 's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.18x versus -- for . Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHHYSonic Healthcare Ltd.1.18x 21.85x -- -- PPCB-- -- -- -$354.3K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 22
Lamb Weston Holdings, Inc. [LW] is down 2.48% over the past day.
Buy
54
BMRN alert for Dec 22
BioMarin Pharmaceutical, Inc. [BMRN] is down 2.35% over the past day.
Buy
82
RKLB alert for Dec 22
Rocket Lab Corp. [RKLB] is up 10% over the past day.
